30Oct
29Oct
SAM Sport’s Ability to Help Athletes Recover from Injury Without Surgery is Gaining Recognition from Enthusiasts Within the Tennis Community
SAM Sport, an FDA-cleared bio regenerative medical device that helps reduce pain associated with tendon, ligament, and muscle injuries is receiving an increased amount of attention for its ability to help tennis players recover without surgery. SAM by ZetrOZ Systems provides proven soft tissue and chronic pain relief through continuous ultrasound treatment. Read more >>
29Oct
ALung and CytoAgents CEOs talk pandemic’s impact on funding, trials
At 3 Rivers Venture Fair, panel discussion, CEOs address what happened when they changed direction due to Covid-19. Including CytoAgents. Read more >>
29Oct
eSight 4 Medical Device for the Visually Impaired, Now Available in the United Kingdom, Germany and France
eSight today announces that its newest vision enhancement technology, eSight 4, is now available in select European countries, expanding its goal of providing sight to people with visual impairment on a global basis. The wearable medical device can be purchased in the United Kingdom, Germany and France, with more countries to be added in 2021. eSight 4 obtained its CE Mark in August, meeting the European Union's standards for health, safety and environmental protections. Read more >>
29Oct
Supporting Entrepreneurs
Ziad Moukheiber President of Boston Harbor Angels is speaking and participating on panels and workshops at Yale University, Babson College and The Technology Institute of Monterey in Mexico to help entrepreneurs better understand fundraising and the angel investing ecosystem. "Entrepreneurs often times know their businesses very well and need some support navigating the fundraising world, especially the angel investing industry" says Ziad Moukheiber. The Boston Harbor Angels community of members is always involved in helping entrepreneurs at all levels and at different...
28Oct
Kalion Inc. Teams with Agile BioFoundry To Win DOE Grant to Advance Bio-based Glucaric Acid
Kalion Inc., along with 8 other companies, was selected by the U.S. Department of Energy to receive $5.7 million in funding with the Agile BioFoundry consortium (agilebiofoundry.org) to advance the fundamental understanding of industrial biotechnology. Kalion Inc. uses machine learning to accelerate the development of high-purity, low-cost glucaric acid. Read more >>
28Oct
Boulder JCC Nosh & Network Panel Discussion: Pivot Business To Possibility
On Wednesday, October 28 from 4:00 – 5:30 pm, we will host a panel discussion on the ways in which COVID-19 required businesses to revisit the way their work is done, including reassessing, reshaping, and refocusing. Four Boulder businesses will share their experience and how they expect their business will change going forward. Panel includes 1908 Brands. Read more >>
28Oct
The Active Fund at Boston Harbor Angels
Boston Harbor Angels launched in 2018 an investment platform for its members and accredited investors " The Active Fund". The Active Fund allows members and accredited investors to invest and support startups in the Boston Harbor Angels ecosystem. "The Active Fund is a private platform allowing a lot of flexibility to our members" said Ziad Moukheiber President of Boston Harbor Angels.
28Oct
Kalion Inc. Teams with Agile BioFoundry To Win DOE Grant to Advance Bio-based Glucaric Acid
Kalion Inc., along with 8 other companies, was selected by the U.S. Department of Energy to receive $5.7 million in funding with the Agile BioFoundry consortium (agilebiofoundry.org) to advance the fundamental understanding of industrial biotechnology. Kalion Inc. uses machine learning to accelerate the development of high-purity, low-cost glucaric acid. Read more >>
28Oct